TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30450865

Group type: EXPERIMENTAL
Intervention: 7.2% saline solution + oral electrolyte solutions (OES)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acetate Ringer solution
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lactate Ringer solution
Number of subjects: 32

Group type: COMPARATOR
Intervention: Isotonic sodium bicarbonate (NaHCO3)
Number of subjects: 32
Study: 27902984

Group type: EXPERIMENTAL
Intervention: Healthy full-term infants
Number of subjects: 24
Study: 25640577

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (1000 impulses)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (acoustic sham)
Number of subjects: 72
Study: 23294668

Group type: EXPERIMENTAL
Intervention: Online self-directed intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Comparison condition (alternative website for self-assessment)
Number of subjects: 180
Study: 20862456

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 57

Group type: COMPARATOR
Intervention: No patch (non-smokers)
Number of subjects: 57
Study: 18350853

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (X group; n = 255)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Xylitol-sorbitol chewing gum (XS group; n = 264)
Number of subjects: 750

Group type: COMPARATOR
Intervention: No gum (C group; n = 231)
Number of subjects: 750
Study: 16233981

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation under local anaesthesia (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sapheno-femoral ligation, stripping and multiple avulsions under general anaesthesia (n=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sapheno-femoral ligation, stripping and multiple avulsions
Number of subjects: 60
Study: 12679946

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 26
Study: 11103751

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally once daily for 4 days
Number of subjects: 8
Study: 7999197

Group type: EXPERIMENTAL
Intervention: Standardized teaching from family medicine faculty or well women teachers
Number of subjects: 70

Group type: COMPARATOR
Intervention: Unstandardized teaching during clinical rotations
Number of subjects: 70
Study: 3396475

Group type: EXPERIMENTAL
Intervention: Cefotaxime (2g IV before surgery)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Cephazolin (2g IV before surgery and after 8 hours)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 552

Group type: COMPARATOR
Intervention: Cephazolin
Number of subjects: 552
Study: 30938383

Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention
Number of subjects: 115

Group type: COMPARATOR
Intervention: Healthy Eating diet (control)
Number of subjects: 115
Study: 28245873

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Atorvastatin 5 mg/ezetimibe 10 mg combination
Number of subjects: 21
Study: 25567031

Group type: EXPERIMENTAL
Intervention: Brief strategic therapy (BST) in conjunction with usual care (UC)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 81
Study: 23446769

Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Nonsurgical Management (NSM)
Number of subjects: 300
Study: 21293900

Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy (compliant patients)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy (non-compliant patients)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Difference in eradication rates between compliant and non-compliant patients
Number of subjects: 307
Study: 20029761

Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) methodology
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Baseline results dissemination
Number of subjects: 328
Study: 17925021

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg caffeine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg caffeine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 15476155

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11841108

Group type: EXPERIMENTAL
Intervention: Superficial acupuncture (needles introduced at a depth of 2 mm)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Deep acupuncture (needles placed deeply in muscular acupuncture points and trigger points)
Number of subjects: 44
Study: 9728836

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine (ROPI)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (BUPI)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2% mepivacaine (MEPI)
Number of subjects: 45
Study: 7759706

Group type: EXPERIMENTAL
Intervention: Streptokinase/subcutaneous heparin
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Streptokinase/intravenous heparin
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Accelerated rt-PA
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1067

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Patent infarct-related artery
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Low ejection fraction
Number of subjects: 1067
Study: 2278332

Group type: EXPERIMENTAL
Intervention: Modified oesophageal detector device
Number of subjects: 20
Study: 110504

Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 1000 microgram/h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 200 microgram/h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 40 microgram/h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 8 microgram/h
Number of subjects: 10
Study: 31807943

Group type: EXPERIMENTAL
Intervention: Intensive multimodal treatment comprising pharmacotherapy and DBT-based cognitive behavioural group psychotherapy (TG)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Clinical management comprising non-specific counselling (CG)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Intensive multimodal treatment (TG)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Clinical management (CG)
Number of subjects: 144
Study: 31216310

Group type: EXPERIMENTAL
Intervention: Machine learning classifiers using an 18-CpG signature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Machine learning classifiers using subsets of the 18-feature aggregate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 18-CpG signature mapped to 13 genes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with previous studies
Number of subjects: 0
Study: 28273587

Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 25622197

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for insomnia (CBTI-BP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 58
Study: 24011524

Group type: EXPERIMENTAL
Intervention: Holladay 1 formula
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: SRK/T formula
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Optimized constant calculations
Number of subjects: 43
Study: 21108620

Group type: COMPARATOR
Intervention: Epidural saline (C group, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.3% ropivacaine (R group, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.3% ropivacaine combined with 1 μg/ml sufentanil (RS group, n=20)
Number of subjects: 60
Study: 19476115

Group type: EXPERIMENTAL
Intervention: Interval exercise training (IET) - 15 min interval exercise sessions, 2 times daily for 3 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Steady state exercise training (SSET) - 5-10 min steady state exercise sessions, 2 times daily for 3 weeks
Number of subjects: 31
Study: 17099122

Group type: EXPERIMENTAL
Intervention: Intervention materials that integrated comparative information on cost, benefits, and quality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control materials
Number of subjects: 0
Study: 14980921

Group type: EXPERIMENTAL
Intervention: Narcotrend index
Number of subjects: 18

Group type: COMPARATOR
Intervention: BIS
Number of subjects: 18
Study: 11816629

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (ET-1) levels
Number of subjects: 64
Study: 9150587

Group type: EXPERIMENTAL
Intervention: High need for closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low need for closure
Number of subjects: 0
Study: 8148355

Group type: EXPERIMENTAL
Intervention: Myristic acid diet
Number of subjects: 59

Group type: COMPARATOR
Intervention: Palmitic acid diet
Number of subjects: 59

Group type: COMPARATOR
Intervention: Oleic acid diet
Number of subjects: 59
Study: 3207070

Group type: EXPERIMENTAL
Intervention: Plethysmography (PG) after 1 year
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Thermography (TG) after 1 year
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Normalization of PG and TG
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Remaining venous obstruction and persistent thermoactivity
Number of subjects: 65
Study: 30105966

Group type: EXPERIMENTAL
Intervention: School-based 'School of 5' handwashing campaign
Number of subjects: 676

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 676
Study: 28471813

Group type: EXPERIMENTAL
Intervention: Teaching intervention targeting cognitive skills to challenge a superior's decision
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group receiving general crisis management instruction
Number of subjects: 50
Study: 26283655

Group type: EXPERIMENTAL
Intervention: Cryoballoon (CB) ablation
Number of subjects: 315

Group type: COMPARATOR
Intervention: Open irrigated radiofrequency (RF) ablation
Number of subjects: 315
Study: 23539696

Group type: EXPERIMENTAL
Intervention: Semuloparin (20 mg subcutaneously once daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Semuloparin and Placebo
Number of subjects: 100
Study: 20861846

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg on demand 1 hour before sexual activity
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 18988428

Group type: EXPERIMENTAL
Intervention: Self‐Regulated Strategy Development Model (n=48, 19 girls and 29 boys)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Social Cognitive Model of Sequential Skill Acquisition (n=31, 15 girls and 26 boys)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Ordinary instruction group (n=32, 9 girls and 23 boys)
Number of subjects: 121
Study: 16895956

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 4 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (healthy young subjects)
Number of subjects: 18
Study: 14620473

Group type: EXPERIMENTAL
Intervention: 24 h dive-PFSI-flight profile
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 18 h dive-PFSI-flight profile
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 12 h dive-PFSI-flight profile
Number of subjects: 102

Group type: COMPARATOR
Intervention: 2 h flight-only control
Number of subjects: 102

Group type: COMPARATOR
Intervention: 3 h flight-only control
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: VGE observed in flights
Number of subjects: 102
Study: 11401043

Group type: EXPERIMENTAL
Intervention: Children with asthma
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Children with asthma from single-parent families
Number of subjects: 236
Study: 8629878

Group type: EXPERIMENTAL
Intervention: Combined therapy (low-dose warfarin [INR <1.5] plus 325 mg/d of enteric-coated aspirin)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Adjusted-dose warfarin therapy (INR 2.0 to 3.0)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Aspirin alone (325 mg/d of enteric-coated aspirin)
Number of subjects: 117
Study: 1280411

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 6143709

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of sulphasalazine and levamisole
Number of subjects: 45
Study: 30885078

Group type: EXPERIMENTAL
Intervention: Spontaneous counselling offered by pharmacists
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Mention of sedation as a side-effect
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Warning against driving after taking the medication
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Warning against dealing with hazardous machinery
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Other side-effects counselling
Number of subjects: 88
Study: 30102493

Group type: EXPERIMENTAL
Intervention: One dose of measles vaccine
Number of subjects: 5084

Group type: EXPERIMENTAL
Intervention: Two doses of measles vaccine
Number of subjects: 5084
Study: 26909482

Group type: EXPERIMENTAL
Intervention: Humulin N®
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gansulin
Number of subjects: 37
Study: 24559010

Group type: EXPERIMENTAL
Intervention: Hydration with plain water or a sports drink during 90 min of spinning exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: No fluid intake during 90 min of spinning exercise
Number of subjects: 21
Study: 22091926

Group type: EXPERIMENTAL
Intervention: Psychosocial stress condition (Trier Social Stress Test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 19243458

Group type: EXPERIMENTAL
Intervention: Self-efficacy in smoking cessation
Number of subjects: 0
Study: 17594937

Group type: EXPERIMENTAL
Intervention: IL-10 at 1 microg/kg/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IL-10 at 4 microg/kg/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IL-10 at 8 microg/kg three times per week
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 14974944

Group type: EXPERIMENTAL
Intervention: EC-MPS 720 mg b.i.d.
Number of subjects: 423

Group type: COMPARATOR
Intervention: MMF 1000 mg b.i.d.
Number of subjects: 423
Study: 11262697

Group type: EXPERIMENTAL
Intervention: MKH glasses (prism glasses)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Orthoptists' glasses (conventional glasses)
Number of subjects: 72
Study: 9676306

Group type: EXPERIMENTAL
Intervention: Group 1: Elevated room temperature to 27-28 degrees C with cotton blankets
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group 2: Room temperature maintained at 27-28 degrees C with aluminum blanket
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group 3: Elevated room temperature combined with a convective heating blanket
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Group 4: Room temperature maintained at 22 degrees C with aluminum blanket
Number of subjects: 50

Group type: COMPARATOR
Intervention: Group 5: Room temperature maintained at 22 degrees C with convective heating device
Number of subjects: 50
Study: 7990473

Group type: EXPERIMENTAL
Intervention: Alcohol cue exposure
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control beverage (water)
Number of subjects: 24
Study: 3055362

Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 60
Study: 29654699

Group type: EXPERIMENTAL
Intervention: Smartphone application (app) for patient support
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Cal/BD cutaneous foam with app
Number of subjects: 122

Group type: COMPARATOR
Intervention: No app (control)
Number of subjects: 122
Study: 27472921

Group type: EXPERIMENTAL
Intervention: Motor timing parameters
Number of subjects: 0
Study: 24378765

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 22554491

Group type: EXPERIMENTAL
Intervention: Statin therapy in polygenic hypercholesterolemia (PH)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Statin therapy in familial combined hyperlipemia (FCH)
Number of subjects: 80
Study: 20597268

Group type: EXPERIMENTAL
Intervention: Warfarin alone (Group 1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Warfarin plus aspirin (Group 2)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Warfarin (both groups)
Number of subjects: 82
Study: 18384420

Group type: EXPERIMENTAL
Intervention: PPMQ-R (Patient Perception of Migraine Questionnaire - Revised)
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: PPMQ-R
Number of subjects: 1304
Study: 16627141

Group type: EXPERIMENTAL
Intervention: Short hydroxyapatite-coated femoral stem
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular hydroxyapatite-coated femoral stem
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study: 12784781

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 3283

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 3283
Study: 10774861

Group type: EXPERIMENTAL
Intervention: 10 ml 0.5% bupivacaine with crystalline corticosteroid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 ml 0.5% bupivacaine with lipoid corticosteroid
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10 ml 0.5% bupivacaine without corticosteroid
Number of subjects: 50
Study: 8741518

Group type: EXPERIMENTAL
Intervention: Electrical tooth stimulation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Preceding tone beep
Number of subjects: 11
Study: 1449617

Group type: EXPERIMENTAL
Intervention: 0.05% NaF rinse
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 1.5% H2O2 rinse with 0.05% NaF
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (1100 ppm F toothpaste only)
Number of subjects: 95
Study: 2413761

Group type: EXPERIMENTAL
Intervention: Intraperitoneal 32% dextran 70
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Intraperitoneal hydrocortisone alone
Number of subjects: 164

Group type: COMPARATOR
Intervention: Adjunct use of intraperitoneal dextran or hydrocortisone
Number of subjects: 164
Study: 30909797

Group type: EXPERIMENTAL
Intervention: Camera-based mirror visual feedback (camMVF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional group (CG)
Number of subjects: 20
Study: 29316012

Group type: EXPERIMENTAL
Intervention: Ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escalated therapy
Number of subjects: 0
Study: 27895406

Group type: EXPERIMENTAL
Intervention: Simplified dyad criteria (combination of proliferation and VS)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Inoue's tetrad criteria
Number of subjects: 147
Study: 25159313

Group type: EXPERIMENTAL
Intervention: Bortezomib-thalidomide-dexamethasone (VTD)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Thalidomide-dexamethasone (TD)
Number of subjects: 474
Study: 22542960

Group type: EXPERIMENTAL
Intervention: Measurement-Based Care (MBC)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 390
Study: 20482346

Group type: EXPERIMENTAL
Intervention: Self-ligating bracket (Damon3)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Self-ligating bracket (SmartClip)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional bracket (Victory Series)
Number of subjects: 43
Study: 18589027

Group type: EXPERIMENTAL
Intervention: Slow eating rate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Quick eating rate
Number of subjects: 30
Study: 16365330

Group type: EXPERIMENTAL
Intervention: Electromagnetic interference (EMI) present during AED operation
Number of subjects: 19
Study: 14645424

Group type: EXPERIMENTAL
Intervention: Intraperitoneal radioactive chromic phosphate (32P)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Cyclophosphamide‐cisplatin (CP)
Number of subjects: 229
Study: 10801758

Group type: EXPERIMENTAL
Intervention: Iodixanol (nonionic dimer)
Number of subjects: 856

Group type: COMPARATOR
Intervention: Ioxaglate (low osmolar ionic agent)
Number of subjects: 856
Study: 8823693

Group type: EXPERIMENTAL
Intervention: Aceclofenac (200 mg daily)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Indomethacin (100 mg daily)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Aceclofenac
Number of subjects: 310

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 310
Study: 1481585

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) stimulation test
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Bromocriptine treatment
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Dopamine agonist therapy
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Low-dose dopamine agonist trial
Number of subjects: 1326
Study: 2934788

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 342
Study: 31120773

Group type: EXPERIMENTAL
Intervention: Generalised Random Gradient (GRG) hyper-heuristic
Number of subjects: 108

Group type: COMPARATOR
Intervention: Randomised Local Search with different neighbourhood sizes
Number of subjects: 108

Group type: COMPARATOR
Intervention: Evolutionary Algorithms using standard bit mutation
Number of subjects: 108
Study: 30666747

Group type: EXPERIMENTAL
Intervention: Nigella sativa (NS) supplementation, 2 grams per day for 6 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nigella sativa (NS) supplementation
Number of subjects: 46
Study: 28355259

Group type: EXPERIMENTAL
Intervention: Amphotericin B 0.5 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amphotericin B 1 mg/kg
Number of subjects: 50